Daiichi Sankyo Sales Slip in FY2020 as Price Cuts, Deal Termination Weigh

April 28, 2021
Daiichi Sankyo said on April 27 that its FY2020 revenue inched down 2% over the previous year as the strong performance of its global strategic products failed to offset the blow from drug price cuts and the termination of a...read more